ArticleEuropean journal of medical research2025
Changing trends in burden of calcific aortic valve diseases and degenerative mitral valve diseases among people aged 60-89 years from 1990 to 2030.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe growing elderly population has increased the prevalence of nonrheumatic valvular heart diseases, such as calcific aortic valve disease (CAVD) and degenerative mitral valve disease (DMVD), raising major health concerns.
methodsThe Global Burden of Disease Study 2019 was used to assess the global burden of CAVD and DMVD. Estimated annual percentage change (EAPC) and joinpoint regression analyzed 30-year trends, while future trends for the next decade were projected using the Nordpred model.
resultsIn 2019, there were 6.9 (95% UI [5.9-8.2]) million CAVD and 15.4 (95% UI [14.6-16.3]) million DMVD cases among the elderly, representing 448% and 85% increases over 30 years, respectively. Deaths rose by 98% for CAVD and 41% for DMVD. DALYs rates dropped from 133.5 (95% UI [121.8-149.0]) to 117.3 (95% UI [104.9-129.0]) for CAVD and from 75.1 (95% UI [62.7-91.2]) to 50.8 (95% UI [42.1-64.8]) for DMVD between 1990 and 2019. Males carried a higher CAVD burden, while females were more affected by DMVD. By 2030, CAVD prevalence is projected to reach 166.1 million, deaths 2.7 million, and DALYs 37.5 million. DMVD cases will increase to 422 million, deaths 751,000, and DALYs 16.3 million.
conclusionsCAVD and DMVD are major contributors to the disease burden in the elderly. Gender, age, and SDI differences highlight the need for tailored prevention strategies, as projections indicate a rising burden through 2030. This study provides critical data to guide global prevention and control efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.